EYWA designs the best processes and products to boost the adoption of psychedelic medicine, harnessing the power of biosynthesis.
EYWA has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
EYWA's investors include GridX, The Ganesha Lab, Draper Cygnus, Tim Draper, GRID EXPONENTIAL.
EYWA is headquartered in Montevideo, Uruguay.
EYWA designs the best processes and products to boost the adoption of psychedelic medicine, harnessing the power of biosynthesis.
EYWA is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EYWA — Funding & Investors." VCBacked, October 3, 2025, https://www.vcbacked.co/company/eywa. Accessed September 30, 2026.
VCBacked. (2025). EYWA — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/eywa
{{cite web |title=EYWA — Funding & Investors |url=https://www.vcbacked.co/company/eywa |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated